diaphorase are identical in brain and peripheral tissues. Proc. Natl.
Acad. Sci. U.S.A 88, 7797–7801.
Gracy, K. N., and V. M. Pickel, 1997: Ultrastructural localization and
comparative distribution of nitric oxide synthase and N-methyl- D-aspartate receptors in the shell of the rat nucleus accumbens.
Brain Res. 747, 259–272.
Hamaoka, K., and T. Sawada, 1987: Hypoplastic heart induced by
neonatal hypothalamic lesions in mice. J. Mol. Cell Cardiol. 19,
741–749.
Hambley, J. W., G. A. Johnston, and L. J. Rogers, 1987: Blood
pressure development in SHR and WKY rats: effects of neonatal
monosodium glutamate treatment and evidence for transient
hypertension in WKY rats. Neurosci. Lett. 83, 190–194.
Holzwarth-McBride, M. A., E. M. Hurst, and K. M. Knigge, 1976:
Monosodium glutamate induced lesions of the arcuate nucleus. I.
Endocrine deficiency and ultrastructure of the median eminence.
Anat. Rec. 186, 185–205.
Hope, B. T., G. J. Michael, K. M. Knigge, and S. R. Vincent, 1991:
Neuronal NADPH diaphorase is a nitric oxide synthase. Proc. Natl.
Acad. Sci. U.S.A 88, 2811–2814.
Izumi, Y., A. M. Benz, D. B. Clifford, and C. F. Zorumski, 1992:
Nitric oxide inhibitors attenuate N-methyl-D-aspartate excitotoxicity in rat hippocampal slices. Neurosci. Lett. 135, 227–230.
Johnson, A. K., and A. D. Loewy, 1990: Circumventricular organs and
their role in visceral functions. In: Central Regulation of Autonomic
Function (A. D. Loewy and K. M. Spyer eds). Oxford: Oxford
University Press, pp. 247–267.
Johren, O., T. Inagami, and J. M. Saavedra, 1995: AT1A, AT1B, and
AT2 angiotensin II receptor subtype gene expression in rat brain.
Neuroreport 6, 2549–2552.
Kristova, V., M. Kriska, P. Babal, and D. Jezova, 1998: Early postnatal glutamate treatment results in altered vascular responsiveness
to serotonin and noradrenaline in adult rats. Endocr. Regul. 32,
133–139.
Lage, R. C., M. J. Campagnole-Santos, M. A. Fontes, and R. A.
Santos, 1999: Cardiovascular effects produced by nitric oxiderelated drugs in the caudal ventrolateral medulla. Neuroreport 10,
731–735.
Lenkei, Z., P. Corvol, and C. Llorens-Cortes, 1995: The angiotensin
receptor subtype AT1A predominates in rat forebrain areas
involved in blood pressure, body fluid homeostasis and neuroendocrine control. Brain Res. Mol. Brain Res. 30, 53–60.
Lewis, S. J., E. J. Whalen, T. G. Beltz, and A. K. Johnson, 1999: Role
of the anterior region of the third ventricle in the cardiovascular
responses produced by systemic injection of a nitric oxide synthase
inhibitor. Brain Res. 830, 191–194.
Lin, L. H. and W. T. Talman, 2000: N-methyl-D-aspartate receptors
on neurons that synthesize nitric oxide in rat nucleus tractus solitarii. Neuroscience 100, 581–588.
Maiter, D., L. E. Underwood, J. B. Martin, and J. I. Koenig, 1991:
Neonatal treatment with monosodium glutamate: effects of prolonged growth hormone (GH)-releasing hormone deficiency on
pulsatile GH secretion and growth in female rats. Endocrinology
128, 1100–1106.
Meister, B., S. Ceccatelli, T. Ho ̈ kfelt, N. E. Anden, M. Anden, and E.
Theodorsson, 1989: Neurotransmitters, neuropeptides and binding
sites in the rat mediobasal hypothalamus: effects of monosodium
glutamate (MSG) lesions. Exp. Brain Res. 76, 343–368.
Moriguchi, S., N. Ohzuru, N. Koga, K. Honda, R. Saito, Y. Takano,
and H. Kamiya, 1998: Central administration of a nitric oxide
synthase inhibitor causes pressor responses via the sympathetic
nervous system and the renin-angiotensin system in Wistar rats.
Neurosci. Lett. 245, 109–112.
Mosqueda-Garcia, R., R. Eskay, N. Zamir, M. Palkovits, and G.
Kunos, 1986: Opioid-mediated cardiovascular effects of clonidine
in spontaneously hypertensive rats: elimination by neonatal
treatment with monosodium glutamate. Endocrinology 118,
1814–1822.
